📰 Planegg News
Page 35 - Planegg News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Planegg. Real-time updates on events, politics, business and more.
June 13, 2022
DGAP-News: MorphoSys AG / Key word: Agreement/Miscellaneous Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® in Combination with TTI-622, a Fusion... | June 13, 2022
June 13, 2022
DGAP-News: MorphoSys AG / Key word(s): Agreement/MiscellaneousPfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47 13.06.2022 / 22:01 The issuer is solely responsible for the content of this announceme...
June 10, 2022
New translational data suggests potential disease-modifying effects following treatment with pelabresib of both first-line and ruxolitinib-relapsed/refractory patients A comparative model suggests
June 1, 2022
Observed Preliminary Efficacy and Safety together with High Complete Remission Rate Strengthens Evidence of Therapy's Potential MARTINSRIED, GERMANY / ACCESSWIRE / June 1, 2022 / LINDIS Biotech GmbH, a
May 21, 2022
MorphoSys (NASDAQ:MOR – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Saturday, Zacks.com reports. According to Zacks, “MorphoSys AG is a biopharmaceutical company. It develops treatment for cancer, inflammations and autoimmune diseases. The company’s proprietary portfolio consists of MOR208, MOR202, MOR103, […]
May 19, 2022
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 18, 2022 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) announced today that its shareholders approved all resolutions proposed by the Company's Management and Supervisory
May 18, 2022
DGAP-News: MorphoSys AG / Key word(s): AGM/EGM MorphoSys AG Reports Outcome of Annual General Meeting 2022 18.05.2022 / 22:02 ...
May 18, 2022
DGAP-News: MorphoSys AG / Key word(s): AGM/EGMMorphoSys AG Reports Outcome of Annual General Meeting 2022 18.05.2022 / 22:02 The issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, May 18, 2022MorphoSys AG Reports Outcome of Annual General Meeting 2022All Proposed...
May 9, 2022
MorphoSys AG (NASDAQ:NASDAQ:MOR) Q1 2022 Earnings Conference Call May 05, 2022, 08:00 AM ET Company Participants Julia Neugebauer - IR Jean-Paul Kress - CEO Sung Lee - CFO Malte Peters -...
May 4, 2022
DGAP-News: MorphoSys AG / Key word(s): Quarterly / Interim Statement MorphoSys AG Reports First Quarter 2022 Financial Results ...